- Home
- FNGR vs ESLA Comparison
FNGR vs ESLA Comparison
Compare FNGR & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNGR | ESLA |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2M | 33.6M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | FNGR | ESLA |
|---|---|---|
| Price | $0.26 | $0.80 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | ★ 334.8K | 43.7K |
| Earning Date | 05-28-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,132,261.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.28 | $0.73 |
| 52 Week High | $2.35 | $3.15 |
Technical Indicators
Market Signals| Indicator | FNGR | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 26.48 | 36.89 |
| Support Level | N/A | $0.73 |
| Resistance Level | $0.45 | $1.28 |
| Average True Range (ATR) | 0.04 | 0.09 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 2.48 | 16.76 |
Price Performance
Historical ComparisonAbout FNGR FingerMotion Inc.
FingerMotion Inc is engaged in the provision of mobile payment and recharge services in the Chinese market. The company's business line includes Telecommunications Products and Services, Value Added Products and Services, Short Message Services (SMS) and Multimedia Messaging Services (MMS); a Rich Communication Services (RCS) platform; Data Insights; and a Video Games Division (inactive). It principally earns revenue by providing mobile payment and recharge services to customers of telecommunications companies in China.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.